

Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102, a viscou⦠read more
Healthcare
Drug ManufacturersāGeneral
5 years
USD
Exclusive to Premium users
$6.67
Price+0.99%
$0.07
$56.594m
Small
-
Premium
Premium
-2405.3%
EBITDA Margin-2435.9%
Net Profit Margin+80.8%
Free Cash Flow Margin-2405.3%
EBITDA Margin-2435.9%
Net Profit Margin+80.8%
Free Cash Flow Margin$33.862m
-28.7%
1y CAGR+5.1%
3y CAGR+9.2%
5y CAGR-$419.677m
-416.2%
1y CAGR-256.4%
3y CAGR-173.9%
5y CAGR-$38.87
-70.2%
1y CAGR-216.7%
3y CAGR-144.0%
5y CAGR-$254.070m
$293.635m
Assets$547.705m
Liabilities$106.359m
Debt36.2%
-0.2x
Debt to EBITDA-$6.590m
+23.1%
1y CAGR+75.0%
3y CAGR+60.9%
5y CAGR